What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry
We help you build habits for lifelong health
Effects of targeting glutamine metabolism in the TME The TME is a complex milieu that surrounds tumor cells, often providing immunosuppressive cover that facilitates immune invasion
The project started in January 2025, posing three questions, on which the research team is currently working through a literature review/mapping of the national and international debates, actors, main categories of research and critical points: - Which are the main forms of marginalization in the access to metabolic resources (water, air, soil, etc.) for people out of heteronormativity